drugset

drugset / Trial / NCT02432937

Corever in the Treatment of Hypertension

NCT02432937 ↗

Phase 3 Completed 134 enrolled TSH Biopharm Corporation Limited

RandomizedParallel-groupDouble-blindTreatment

Summary

The study primarily aims to compare the effects of two doses of Corever with placebo in patients with hypertension.

Timeline

Start: 2015-01
Primary completion: 2016-06
Completion: 2016-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Corever	Unknown	—	—

Indications